Tetanus Toxoid (Vaccine, Tetanus)

01/01/2015 - "Rapid testing for tetanus on serum or blood allows for an immediate evaluation of individual protection against tetanus in developed countries, using a "single step" immunochromatographic technique using tetanus toxoid. "
06/01/1998 - "The data demonstrate that a limited-dose regimen of maternal tetanus toxoid provides significant and extended protection against the risk of neonatal tetanus death."
02/01/2014 - "A nonadjuvanted transcutaneous tetanus patch is effective in boosting anti-tetanus toxoid immune responses."
01/01/2005 - "Only active immunisation by tetanus vaccine provides effective protection against tetanus intoxication. "
04/01/1979 - "Immunization with tetanus toxoid was effective in reducing the incidence of tetanus."

07/01/2000 - "This practice would reduce the risks of girls exposed to infection through unsafe abortions, and may be the best option for countries seeking to improve their vaccination schedule, especially where tetanus vaccine coverage in pregnant women is unacceptably low."
05/01/2002 - "Moreover, a normal CD4(+) response to tetanus toxoid was found in both chronic HCV carriers and patients who had eliminated the infection. "
08/01/1994 - "Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine."
01/01/1994 - "Specific applications of this approach include the worldwide practice of maternal immunization with tetanus toxoid vaccine and ongoing studies of maternal immunization to prevent Haemophilus influenzae type b, group B streptococcal, pneumococcal, meningococcal, and human immunodeficiency virus infection in the infant. "
05/07/2013 - "We compared the cellular immune response (assessed in terms of IFN-γ production) to tetanus toxoid and to cytomegalovirus in a series of 13 HIV-perinatally-infected children and adolescents with optimal immunovirological response to first line antiretroviral therapy, implemented during chronic infection. "

10/13/2011 - "The current study aimed to evaluate immunogenicity and safety of a newly developed diphtheria-tetanus toxoid (Td) vaccine, GC1107 (Green Cross Corporation, Yongin, Korea), in comparison with placebo and active comparator (licensed Td vaccine) in healthy Korean adults. "
11/01/2006 - "With regard to the latter, the present study explores the possibility of testing both diphtheria and tetanus toxoid potencies using serum from the same animals."
01/01/2002 - "The study also investigated whether sera from the same immunised guinea pigs can be used for potency determination of both the diphtheria and the tetanus toxoid components. "
08/31/1996 - "Incidence of adverse reactions after administration of high dose diphtheria with tetanus vaccine to school leavers: retrospective questionnaire study."
01/22/1996 - "In this study a histological and clinical evaluation of the effects of two different adjuvants in a vaccine containing detoxified diphtheria (DT) and tetanus toxoid (TT) in guinea pigs was done. "

09/11/2015 - "pertussis (BP) and tetanus toxoid (TT), in HIV-exposed, uninfected infants. "
11/01/2013 - "A retrospective cohort study was conducted on infants of mothers delivering at an inner-city hospital in October 2009 where postpartum maternal tetanus toxoid, reduced diptheria toxoid and acellular pertussis (Tdap) vaccination had been initiated in May 2008. "
05/01/2007 - "Male rats were injected with the Pertussis-Diphteria-Tetanus vaccine into the abdominal cavity and purified prostate protein and Freund's complete adjuvant intradermally at 0 and 30 days. "
11/01/2005 - "pertussis strain 186, purified, and covalently linked to a monomer fraction of tetanus toxoid. "
02/24/1986 - "pertussis and tetanus toxoid vaccine induced a beta-adrenoceptor blockade; the acellular vaccine was less effective. "

12/27/2010 - "Measles and tetanus toxoid IgGs were measured quantitatively by using ELISA (American Research Products Inc., Belmont, MA). "
12/04/2004 - "Measles and tetanus toxoid immunisation were not affected. "
05/01/1996 - "Neonatal antibody levels to tetanus toxoid, measles, and S. "
11/01/1990 - "OPV increased from 46.5 to 73.6%, DPT from 49.1 to 75.5%, BCG from 48.7 to 72.2%, measles from 8.6 to 45.8% and tetanus toxoid (TT) for pregnant women (PW) from 41.8 to 65.3%. "
05/01/1995 - "Measles, polio and tetanus toxoid antibody levels in Gambian children aged 3 to 4 years following routine vaccination."